The Phase II Small Business Technology Transfer Research (STTR) grant which will support the next two years of research will focus on extending a systems biology-cheminformatics approach to
Renaissance with the acquisition of Denavir has established a new subsidiary, Prestium Pharma (Prestium), to commercialize branded products in the US. Denavir is a topical antiviral used to
If overdosed, Opioid pain medications such as Hydromorphone, have life-threatening consequences including respiratory depression, low blood pressure and reduced heart rate including circulatory collapse. The affected product with
Under the agreement, Cambrex will manufacture and deliver Phase 3 and pre-launch quantities of the product candidate. Depending on regulatory developments, the timing of completion of capacity expansion
The divested brands include Valtrex, Lamictal, Timentin, Amoxil and Aropax whose total sales were approximately £83m in 2011 and approximately £31m in the first half of 2012. The
SNS01-T met the criteria for Stable Disease in two of the three evaluable patients that comprised first cohort. No drug-related serious adverse events or dose limiting toxicities were
The Phase II trial will be potentially followed by a larger multi-national Phase III study in the US, Europe and India, according to the company. Pluristem chairman, president
The double-blind, dose escalation trial will enrol approximately 150 volunteers with moderate-to-severe HSV-2 infection who are otherwise healthy. The placebo-controlled study is designed to evaluate the safety and
Cordlife Group CEO Jeremy Yee said in recent years Cordlife has successfully brought the benefits of umbilical cord blood banking to numerous people in multiple regions across China.
The acquisition will enable IMS Health’s clients to enhance the speed, efficiency and cost-effectiveness of their trial planning and management activities. As part of the acquisition, IMS will
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.